Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 9.8%

Pulse Biosciences, Inc. (NASDAQ:PLSEGet Free Report) shares were down 9.8% on Friday . The company traded as low as $13.02 and last traded at $13.13. Approximately 173,716 shares changed hands during trading, a decline of 14% from the average daily volume of 201,247 shares. The stock had previously closed at $14.55.

Pulse Biosciences Trading Down 14.9 %

The business’s 50-day moving average is $8.86 and its two-hundred day moving average is $9.26.

Pulse Biosciences (NASDAQ:PLSEGet Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported ($0.17) EPS for the quarter.

Insiders Place Their Bets

In other Pulse Biosciences news, CEO Burke Thomas Barrett purchased 10,000 shares of the stock in a transaction dated Monday, May 20th. The shares were bought at an average price of $8.56 per share, with a total value of $85,600.00. Following the completion of the transaction, the chief executive officer now directly owns 10,000 shares in the company, valued at approximately $85,600. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 71.50% of the company’s stock.

Hedge Funds Weigh In On Pulse Biosciences

Hedge funds have recently bought and sold shares of the company. BNP Paribas Financial Markets grew its stake in Pulse Biosciences by 63.6% during the first quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after acquiring an additional 2,952 shares in the last quarter. Price T Rowe Associates Inc. MD bought a new stake in shares of Pulse Biosciences in the 1st quarter worth approximately $88,000. Cetera Advisors LLC bought a new stake in shares of Pulse Biosciences in the 1st quarter worth approximately $109,000. PNC Financial Services Group Inc. bought a new stake in shares of Pulse Biosciences in the 4th quarter worth approximately $242,000. Finally, Inspire Investing LLC boosted its position in Pulse Biosciences by 32.1% during the 1st quarter. Inspire Investing LLC now owns 41,358 shares of the company’s stock valued at $360,000 after buying an additional 10,039 shares during the period. Hedge funds and other institutional investors own 76.95% of the company’s stock.

About Pulse Biosciences

(Get Free Report)

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.

Further Reading

Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.